Page last updated: 2024-08-24

iobitridol and Coronary Disease

iobitridol has been researched along with Coronary Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bax, JJ; de Roos, A; Jukema, JW; Lamb, HJ; Salm, LP; Schuijf, JD; van der Wall, EE1
Hammerstingl, R; Honold, E; Mohajeri, H; Vogl, TJ; Wolf, M1
Bach, R; Gerk, U; Jung, F; Mrowietz, C1

Trials

1 trial(s) available for iobitridol and Coronary Disease

ArticleYear
Influence of a new monomeric nonionic radiographic contrast medium (iobitridol-350 versus NaCl) on cutaneous microcirculation: single-center, prospective, randomized, double-blind phase IV study in parallel group design.
    Microvascular research, 2000, Volume: 60, Issue:3

    Topics: Aged; Blood Flow Velocity; Blood Viscosity; Cardiac Catheterization; Contrast Media; Coronary Disease; Double-Blind Method; Female; Humans; Injections, Intra-Arterial; Iohexol; Male; Microcirculation; Middle Aged; Prospective Studies; Radiography; Skin

2000

Other Studies

2 other study(ies) available for iobitridol and Coronary Disease

ArticleYear
Noninvasive coronary imaging and assessment of left ventricular function using 16-slice computed tomography.
    The American journal of cardiology, 2005, Mar-01, Volume: 95, Issue:5

    Topics: Contrast Media; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Coronary Stenosis; Echocardiography; Female; Graft Occlusion, Vascular; Humans; Iohexol; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Stents; Tomography, X-Ray Computed; Ventricular Dysfunction, Left

2005
Safety of iobitridol in the general population and at-risk patients.
    European radiology, 2006, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asthma; Body Mass Index; Child; Child, Preschool; Contrast Media; Coronary Disease; Diabetes Complications; Female; Humans; Hypersensitivity; Hypertension; Hypotension; Iohexol; Male; Middle Aged; Premedication; Product Surveillance, Postmarketing; Risk Factors; Safety; Sex Factors

2006